Related Experiment Video
Updated: Sep 28, 2025

12:56
Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
Published on: December 19, 2017
7.9K
Electrical neurostimulation in glaucoma with progressive vision loss.
Carl Erb1, Sophie Eckert2, Pia Gindorf1
1Augenklinik Wittenbergplatz, Berlin, Germany.
Bioelectronic Medicine
|April 1, 2022
Summary
Electrical optic nerve stimulation (ONS) offers a novel approach for glaucoma patients experiencing vision loss. Long-term data show ONS halted progression in over 63% of eyes, demonstrating its clinical efficacy beyond intraocular pressure reduction.
Area of Science:
- Ophthalmology
- Neuroscience
- Medical Technology
Background:
- Glaucoma with progressive vision loss requires treatments beyond intraocular pressure (IOP) reduction.
- Electrical optic nerve stimulation (ONS) is explored as a novel therapeutic strategy.
Purpose of the Study:
- To evaluate the long-term clinical efficacy of electrical ONS in glaucoma patients with progressive vision loss.
- To provide real-world evidence for the effectiveness of ONS.
Main Methods:
- Retrospective study of 70 glaucoma patients undergoing electrical ONS.
- Stimulation involved bipolar rectangular pulses delivered to closed eyes.
- Visual function assessed via static threshold perimetry at baseline and approximately one year post-ONS.
Main Results:
- Mean defect (MD) significantly decreased from 14.0 dB to 13.4 dB (p < 0.01) in 101 eyes.
- Over 63% of eyes (64 eyes) showed stable or improved MD post-ONS.
- 37 eyes experienced an increase in MD from 14.9 dB to 15.6 dB.
Conclusions:
- Electrical ONS demonstrates long-term efficacy in halting glaucoma progression in a significant portion of patients.
- ONS represents a promising alternative treatment for preserving visual function in advanced glaucoma.
- Further research can build upon these findings to refine ONS protocols.
Related Concept Videos
Open Angle Glaucoma: Treatment
719
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
719
Angle Closure Glaucoma: Treatment
845
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
845
Glaucoma: Overview
926
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
926

